Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core Net Income: $17,411M in FY2025, up 10.5% from a year earlier.
Latest, FY2025
17,411
Period ended Dec 31, 2025
Change on a year earlier
+10.5%
15,755 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Form 6-K (0001114448-26-000007)
Where the FY2025 figure comes from
“|| Core net income | 3 889 | 3 933 | -1 | -2 | 17 411 | 15 755 | 11 | 12”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core Net Income ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17,411 | +10.5% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 15,755 | – | Novartis Form 6-K (0001114448-26-000007) ↗ |
Breakdown
What makes up core Net Income
Cite this data
StockData. (2026). Novartis Core Net Income ($M), annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-net-income
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.